111 (YI) Director Chen Yang Luke Sells $389 of Stock

Insider Buying and Selling at 111, Inc.

Chen Yang Luke, an insider at 111, Inc. (NasdaqGM:YI), executed a sale of 1,440 shares on May 26, 2026. The transaction was completed at a price of $0.27 per share, resulting in a total value of $388.80. Insider transactions like this one offer a window into how key stakeholders manage their personal portfolios, though they do not automatically signal a shift in corporate direction.

Recent Buying Activity by Chen Yang Luke

This small sale contrasts sharply with aggressive accumulation earlier in the month. On May 11, 2026, Chen acquired 54,759 shares of the company. Just one day later, on May 12, 2026, Chen added another 413,168 shares. Fellow insider Sun Jian David has also been active, picking up 378,737 shares on May 11, 2026, and 413,168 shares on May 12, 2026. Those larger purchases built upon positions established in prior years, including a substantial block of 126,295 shares bought by Chen on September 8, 2023, and an acquisition by Sun on September 12, 2018.

Stock Valuation and Price Context

Shares of 111, Inc. recently traded around $4.57. The stock has experienced a wide trading span over the past year, reaching a 52-week high of $11.17 and dropping to a 52-week low of $2.48. Short-term momentum places the 50-day moving average at $3.64, while the longer-term 200-day moving average rests higher at $5.09. With a market capitalization of roughly $32.11 million, the healthcare distributor operates in a volatile space where share prices frequently swing. <EOF>

Company Background in Healthcare Distribution

Headquartered in Shanghai, China, 111, Inc. runs an integrated digital and physical platform focused on the healthcare sector. The firm operates through business-to-consumer and business-to-business channels, offering supply chain integration, product promotion, customer analytics, and online wholesale pharmacy services. It also provides cloud-based inventory management tools, automated salesforce applications, and online medical consultations.

What to Watch Next for 111, Inc.

Market participants tracking the firm will keep an eye on upcoming regulatory filings, corporate updates, and future earnings reports to gauge financial health. Given the negative earnings per share of $1.79 and a net profit margin of roughly negative 1.01%, observers will look for signs of operational turnaround. Future Form 4 filings will also clarify whether recent insider moves represent a broader trend of position trimming or merely routine portfolio management.